Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
3
×
boston top stories
life sciences
national blog main
boston
clinical trials
medical device
national top stories
new york blog main
new york top stories
startups
venture capital
20/20 healthcare partners
alder biopharmaceutical
allergan
american academy of neurology
amgen
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
antisense oligonucleotide
atogepant
benzodiazepines
biogen
biohaven
blackstone group
blackstone life sciences
bob azelby
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
calcitonin gene-related peptide
christian angermayer
columbia university
david goldstein
depression
detroit blog main
detroit top stories
What
drugs
3
×
neuro
3
×
new
companies
therapies
aims
approval
arguments
associated
backed
big
cause
ceo
class
commercialized
competitors
decades
develop
device
dialysis
disease
diseases
drug
enclear
epilepsy
fda
genes
genetic
harmful
links
make
marcio
medicines
meeting
migraine
mutations
nets
neurodegenerative
oral
potential
Language
unset
Current search:
xconomy.com
×
drugs
×
" boston blog main "
×
neuro
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments